BERWYN, Pa., Oct. 03, 2024–(BUSINESS WIRE)–AscellaHealth, a global partner providing customizable solutions to support the specialty pharmaceutical industry, announces that the Company has been identified as one of the fastest growing companies in the region. Listmakers are required to be headquartered in Greater Philadelphia, be independently owned without a parent company, have consistent revenue growth from 2021-2023 and a minimum revenue of $750,000 in 2021.
“This recognition underscores the significant value we provide to the global life sciences and healthcare industry as we expand our international presence and drive business growth,” says Dea Belazi, CEO, AscellaHealth. “As a trusted partner in the specialty pharmaceutical industry, we attribute our outstanding achievements to the dedication, expertise and efforts of our entire organization. Every day, our dedicated professional teams focus on patient care, enabling AscellaHealth to provide effectively deliver essential healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharmaceutical companies.”
Each year, the Philadelphia Business Journal aims to recognize Greater Philadelphia’s fastest-growing companies based on average two-year revenue growth. Formerly known as Soaring 76, the Business Journal renamed the program this year Philly’s Fast 50, which puts the emphasis on private companies. This marks AscellaHealth’s fourth time on the list.
To determine the list, the Business Journal solicited online nominations from private companies. Those that met this year’s parameters were then vetted through a process involving the Business Journal’s editorial board and this year’s accounting partner, CLA. In a move with the program’s roots, a single spot was reserved on this year’s list for the region’s fastest-growing public company.
“As a leading global specialty pharmaceutical provider, AscellaHealth is committed to advancing its patient-centered care model and demonstrates a strong commitment to creating innovative solutions and programs that deliver unique value to our customers, partners and patients. ,” says Bill Oldham, chairman and president of AscellaHealth. “Our continued corporate growth is focused on improving clinical outcomes for patients with complex, chronic conditions and rare diseases, while also addressing the needs of payers and health plans for more effective management of medical and pharmacy costs. Our impressive revenue growth of 746.1% in the past three years reflects our success in the industry.”
About AscellaHealth LLC
AscellaHealth is a global partner providing proven end-to-end solutions to both life sciences and healthcare companies to improve the quality of life for patients with complex and chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients ensuring an efficient flow of funds between payers and pharmacy. Visit www.AscellaHealth.com.
About the Philadelphia Business Journal
The Philadelphia Business Journal is the leading media solutions platform for companies strategically targeting business decision makers. Media Products provides comprehensive business news coverage from a local, regional and national perspective by publishing daily stories on its website, social media and weekly edition available in print and online. The Philadelphia Business Journal is part of American City Business Journals (ACBJ) that delivers a total business audience of over 10 million people through our websites and publications and nearly 1,000 major annual industry events. ACBJ owns 44 business publications across the country that provide exclusive and in-depth business coverage.
In addition, ACBJ owns and operates AmericanInno, BizWomen, BizEquity and Hemmings. ACBJ is a unit of Advance Publications, Inc.
Check out the source version at businesswire.com: https://www.businesswire.com/news/home/20241003434375/en/
contacts
Media:
Nicole Dufour
CPR communications
ndufour@cproonline.com
201.641.1911 x 54